28 Aug Health Ivosenib 250 mg (Ivosidenib): Enhancing Survival Rates in AML & Cholangiocarcinoma 28/08/2025 By Dipesh Ivosenib 250mg is a targeted cancer therapy that contains Ivosidenib, an oral, small-molecule inhibitor designed to block the activity ...Continue reading
21 Aug Health Enasinib 50mg: Promoting Differentiation in AML Cells 21/08/2025 By Dipesh Enasinib 50mg contains Enasidenib, a targeted cancer therapy used in the treatment of certain types of leukemia. Developed as part of t...Continue reading